Two Sigma Investments, LP Mirum Pharmaceuticals, Inc. Transaction History
Two Sigma Investments, LP
- $41.6 Billion
- Q4 2024
A detailed history of Two Sigma Investments, LP transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 126,446 shares of MIRM stock, worth $6.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
126,446
Previous 227,473
44.41%
Holding current value
$6.6 Million
Previous $8.87 Million
41.07%
% of portfolio
0.01%
Previous 0.02%
Shares
17 transactions
Others Institutions Holding MIRM
# of Institutions
211Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$343 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$239 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$169 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$146 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$136 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.92B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...